You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ly3437943

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Daytona Beach (LY3437943)

Not yet recruiting
  • Healthy
  • LY3437943
  • Daytona Beach, Florida
    LabCorp CRU, Inc
Jul 17, 2023

Overweight Trial in South Miami, San Antonio (LY3437943, Ethinyl Estradiol, Drospirenone)

Not yet recruiting
  • Overweight
  • LY3437943
  • +2 more
  • South Miami, Florida
  • +1 more
Sep 11, 2023

Healthy Trial in Miami, San Antonio, Salt Lake City (LY3437943, Test, Reference)

Not yet recruiting
  • Healthy
  • LY3437943
  • +2 more
  • Miami, Florida
  • +2 more
Aug 16, 2023

Healthy, Hepatic Insufficiency Trial in DeLand, Miami, San Antonio (LY3437943)

Not yet recruiting
  • Healthy
  • Hepatic Insufficiency
  • LY3437943
  • DeLand, Florida
  • +3 more
Jun 15, 2023

Overweight, Obesity Trial in Cheng Du, Beijing (LY3437943, Placebo)

Recruiting
  • Overweight
  • Obesity
  • LY3437943
  • Placebo
  • Cheng Du, Sichuan, China
  • +1 more
Dec 8, 2022

Obesity Trial in Daytona Beach, Dallas (LY3437943, Midazolam, Warfarin)

Active, not recruiting
  • Obesity
  • LY3437943
  • +3 more
  • Daytona Beach, Florida
  • +1 more
Nov 9, 2022

Healthy, Renal Insufficiency Trial in Orlando, Saint Paul (LY3437943)

Recruiting
  • Healthy
  • Renal Insufficiency
  • LY3437943
  • Orlando, Florida
  • +1 more
Dec 8, 2022

Diabetes, Type 2 Trial in Japan (LY3437943, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • LY3437943
  • Placebo
  • Suita-shi, Osaka, Japan
  • +3 more
Aug 19, 2022

Overweight or Obesity, CKD, Type 2 Diabetes Trial in Worldwide (LY3437943, Placebo)

Not yet recruiting
  • Overweight or Obesity
  • +2 more
  • LY3437943
  • Placebo
  • Canoga Park, California
  • +19 more
Jun 30, 2023

Obesity, Overweight Trial in Puerto Rico, United States (LY3437943, Placebo)

Active, not recruiting
  • Obesity
  • Overweight
  • LY3437943
  • Placebo
  • Scottsdale, Arizona
  • +27 more
May 10, 2022

Diabetes, Type 2 Trial in United States (LY3437943, Dulaglutide, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • LY3437943
  • +2 more
  • Anaheim, California
  • +3 more
Jan 18, 2021

Type 2 Diabetes Trial in Puerto Rico, United States (LY3437943, Dulaglutide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • LY3437943
  • +2 more
  • Sheffield, Alabama
  • +42 more
Feb 18, 2022

Healthy Trial in Singapore (LY3437943, Placebo)

Completed
  • Healthy
  • LY3437943
  • Placebo
  • Singapore, Singapore
    Lilly Centre for Clinical Pharmacology
Aug 5, 2019